Deals
Mylan Said to Raise Meda Takeover Offer to 44 Billion Kronor
This article is for subscribers only.
Mylan Inc., the biggest U.S. maker of generic medicines, raised its offer for Swedish drugmaker Meda AB to about 43.8 billion Swedish kronor ($6.7 billion), people with knowledge of the matter said.
An all-stock offer of 145 kronor a share was sent this week, said the people, who asked not to be identified discussing confidential information. A previous Mylan bid was rejected by Meda, the Swedish company said on April 4, without saying why or what the offer was. Before the first offer became public Meda was worth about 23.9 billion kronor.